Gastroenterology

Gastroenterology

Volume 152, Issue 1, January 2017, Pages 206-217.e2
Gastroenterology

Original Research
Full Report: Basic and Translational—Alimentary Tract
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease

https://doi.org/10.1053/j.gastro.2016.09.032Get rights and content

Background & Aims

The inflammatory bowel diseases (IBD) ulcerative colitis (UC) and Crohn’s disease (CD) cause significant morbidity and are increasing in prevalence among all populations, including African Americans. More than 200 susceptibility loci have been identified in populations of predominantly European ancestry, but few loci have been associated with IBD in other ethnicities.

Methods

We performed 2 high-density, genome-wide scans comprising 2345 cases of African Americans with IBD (1646 with CD, 583 with UC, and 116 inflammatory bowel disease unclassified) and 5002 individuals without IBD (controls, identified from the Health Retirement Study and Kaiser Permanente database). Single-nucleotide polymorphisms (SNPs) associated at P < 5.0 × 10−8 in meta-analysis with a nominal evidence (P < .05) in each scan were considered to have genome-wide significance.

Results

We detected SNPs at HLA-DRB1, and African-specific SNPs at ZNF649 and LSAMP, with associations of genome-wide significance for UC. We detected SNPs at USP25 with associations of genome-wide significance for IBD. No associations of genome-wide significance were detected for CD. In addition, 9 genes previously associated with IBD contained SNPs with significant evidence for replication (P < 1.6 × 10−6): ADCY3, CXCR6, HLA-DRB1 to HLA-DQA1 (genome-wide significance on conditioning), IL12B, PTGER4, and TNC for IBD; IL23R, PTGER4, and SNX20 (in strong linkage disequilibrium with NOD2) for CD; and KCNQ2 (near TNFRSF6B) for UC. Several of these genes, such as TNC (near TNFSF15), CXCR6, and genes associated with IBD at the HLA locus, contained SNPs with unique association patterns with African-specific alleles.

Conclusions

We performed a genome-wide association study of African Americans with IBD and identified loci associated with UC in only this population; we also replicated IBD, CD, and UC loci identified in European populations. The detection of variants associated with IBD risk in only people of African descent demonstrates the importance of studying the genetics of IBD and other complex diseases in populations beyond those of European ancestry.

Section snippets

Study Design

We conducted 2 GWAS using independent case-control datasets, totaling 2345 AA IBD cases (1646 CD, 583 UC, and 116 IBD unclassified) and 5002 population controls (Figure 1) from unrelated, self-identified AAs individuals. Samples with IBD from GWAS1 (n = 1258 IBD cases [843 CD, 368 UC, 47 unclassified]) were recruited by Johns Hopkins Multicenter African American IBD Study (coordinated by Johns Hopkins IBD Genetics Research Center of the National Institute of Diabetes and Digestive and Kidney

Results

The top associations per locus for UC, CD, and IBD are listed in Table 1. From the meta-analysis of UC, 5 SNPs on chromosome 19 and 41 SNPs in the HLA region achieved GWS with internal replication (Figure 2A and Supplementary Table 1). The chromosome 19 SNPs map to the transcriptional repressor ZNF649 (Supplementary Figure 3) and overlap ZNF649 antisense RNA1 (ZNF649-AS1). A second novel GWS association was detected at African-specific variant rs72947885 in the axonal neuronal adhesion molecule

Discussion

In this first AA GWAS for IBD, we provide the first GWS evidence for AA IBD loci; we identified 2 novel and African-specific GWS UC loci (ZNF649 and LSAMP), and elevate our prior UC HLA association in the region of the DRB1 gene to certainty with GWS evidence. We provide GWS HLA association for IBD unrelated to the UC association and driven mostly by African-specific polymorphisms, and we establish the USP25 locus as GWS in AAs. We also found increased association evidence in AAs for NOD2 (via

Acknowledgments

The authors are grateful to the affected and unaffected individuals who participated in this study. The authors thank the coordinators and research assistants who helped in the recruitment of subjects.

Author contributions: S.R.B., D.J.C., J.H.C., D.P.B.M., and S.K. conceived and designed the study. S.R.B., D.T.O., C.L.S., D.J.C., T.H., J.P.B., P.C., F.B., M.E.Z., D.P.B.M., and S.K. performed analysis and interpretation of data. S.R.B., J.P., A.K., C.H., S.V., Z.W., K.T., L.J.H., J-M.A.K.,

References (31)

  • B.D. Ye et al.

    Identification of ten additional susceptibility loci for ulcerative colitis through immunochip analysis in Koreans

    Inflamm Bowel Dis

    (2016)
  • S.K. Yang et al.

    Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans

    Inflamm Bowel Dis

    (2015)
  • A. Basson et al.

    The association between race and Crohn's disease phenotype in the Western Cape population of South Africa, defined by the Montreal Classification System

    PLoS One

    (2014)
  • N. Griglione et al.

    A comparison of abdominal surgical outcomes between African-American and Caucasian Crohn's patients

    Int J Colorectal Dis

    (2014)
  • M.A. Sofia et al.

    Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital

    Dig Dis Sci

    (2014)
  • Cited by (107)

    • Inflammatory bowel disease in sub-Saharan Africa: epidemiology, risk factors, and challenges in diagnosis

      2022, The Lancet Gastroenterology and Hepatology
      Citation Excerpt :

      Although linkage between all these mutations and the pathogenesis of IBD is plausible, numbers of cases were small, and these findings have not been validated in other studies. The reported non-association between NOD2 polymorphisms in sub-Saharan African populations and the paucity of other apparent risk loci for Crohn's disease in African American populations could suggest that genetic susceptibility confers a smaller degree of risk in African populations.19 This notion is supported by a South African cross-sectional study in which no Black African patients with Crohn's disease reported a family history of IBD, compared with 14% of White South African patients.25

    View all citing articles on Scopus

    Conflicts of interest The authors disclose no conflicts.

    Funding The National Institutes of Health (NIH) Grants DK062431 (S.R.B.), DK087694 (S.K.), DK062413 (D.P.B.M and K.T), DK046763-19, AI067068 and U54DE023789-01 (D.P.B.M.), DK062429, DK062422 (J.H.C.), DK062420 (R.H.D.), DK062432 (J.D.R.), and DK062423 (M.S.S.) supported this study. S.K. was supported by the endowed professorship from Marcus foundation; S.R.B. was supported by grant from Harvey M. and Lynn P. Meyerhoff Inflammatory Bowel Disease Center, the Morton Hyatt Family, the Buford and Linda Lewis family; D.P.B.M. was supported by the Joshua L and Lisa Z Greer Endowed Chair, grant 305479 from the European Union, and The Leona M. and Harry B. Helmsley Charitable Trust; C.L.S was supported in part by the intramural research program of the National Human Genome Research Institute (NIH). The Health and Retirement Study genetic data is sponsored by the National Institute on Aging (grant numbers U01AG009740, RC2AG036495, and RC4AG039029) and was conducted by the University of Michigan.

    Author names in bold designate shared co-first authorship.

    Authors share co-first authorship

    §

    Authors share co-senior authorship.

    View full text